However, NICE guidance on obesity management (CG189) and the NICE Clinical Knowledge Summary (CKS) for PCOS do not currently include GLP-1 receptor agonists as recommended treatment options specifically for PCOS
During Q4 2024, CivicScience reported that nearly two-thirds of current GLP-1 users were adjusting their shopping habits since starting the medication
As you guys know, there's been a shortage of Ozempic pens in Canada, and I chose to look at it as a positive situation to see how my body would react without the medication
00:14:13 Steve Small: Yeah, and despite this, the labeling on Wegovy and other GLP-1s approved for weight loss do mention suicidal behavior as a warning
Also, prevent damage from UV rays, regenerate and repair tissues, lighten hyperpigmentation
Chapter 3 - age-related physiological changes: an overview